- Pharmaceutical companies
- Regeneron Pharmaceuticals
Regeneron Pharmaceuticals
Phone: +1 914-847-7000
Web: https://www.regeneron.com
| Type | Public |
|---|---|
| Traded as |
|
| Industry | Pharmaceuticals; Biotech |
| Founded | 1988 (1988) |
| Headquarters | Eastview/Tarrytown, New York, US (global headquarters) |
| Area served | Global |
| Key people | Leonard Schleifer (CEO) George Yancopoulos (CSO) |
| Revenue | |
| Net income | |
| Total assets | |
| Number of employees | 9,123 (2020) |
| Website | www.regeneron.com |
Regeneron (NASDAQ: REGN) is a leading biotechnology company that invents life-transforming medicines for people with serious diseases. Founded and led for over 30 years by physician-scientists, our unique ability to repeatedly and consistently translate science into medicine has led to seven FDA-approved treatments and numerous product candidates in development, all of which were homegrown in our laboratories. Our medicines and pipeline are designed to help patients with eye disease, allergic and inflammatory diseases, cancer, cardiovascular and metabolic diseases, infectious diseases, pain and rare diseases. Regeneron is accelerating and improving the traditional drug development process through our proprietary VelociSuite® technologies, such as VelocImmune® which produces optimized fully-human antibodies, and ambitious research initiatives such as the Regeneron Genetics Center®, which is conducting one of the largest genetics sequencing efforts in the world.
For detailed contact information visit location pages below.
Regeneron Pharmaceuticals's locations around the world
Clinical Trials sponsored by Regeneron Pharmaceuticals
-
Regeneron PharmaceuticalsJeszcze nie rekrutacja
-
Regeneron PharmaceuticalsJeszcze nie rekrutacja
-
Regeneron PharmaceuticalsRekrutacyjnyMASLD | Stłuszczeniowa choroba wątroby związana z zaburzeniami metabolicznymiStany Zjednoczone
-
Regeneron PharmaceuticalsJeszcze nie rekrutacjamCRPC | Przerzutowy rak prostaty oporny na kastrację
-
Regeneron PharmaceuticalsJeszcze nie rekrutacja
-
Regeneron PharmaceuticalsJeszcze nie rekrutacjaMiejscowo zaawansowany rak podstawnokomórkowy
-
Regeneron PharmaceuticalsRekrutacyjnyNadwaga lub otyłośćStany Zjednoczone
-
Regeneron PharmaceuticalsRekrutacyjnyJaskra pierwotna otwartego kąta (POAG) | Nadciśnienie oczne (OHT)Stany Zjednoczone
-
Regeneron PharmaceuticalsRekrutacyjnyNawracający/oporny na leczenie szpiczak mnogi (RRMM)Stany Zjednoczone
-
Regeneron PharmaceuticalsJeszcze nie rekrutacjaFibrodysplasia Ossificans Progressiva | FIRCYK